Regulatory Affairs and IND/IDE Submission Support
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract pertains to regulatory affairs support focused on preparing and submitting Investigational New Drug (IND) and Investigational Device Exemption (IDE) applications to the U.S. Food and Drug Administration to enable clinical testing of biomedical technologies. The work must ensure full compliance with federal regulatory standards and requirements governing the initiation of human clinical trials, requiring expert knowledge of FDA pathways, documentation protocols, and submission timelines. This subcontract is issued under the Department of Defense, specifically by the Defense Advanced Research Projects Agency, and aligns with NAICS code 541611 for administrative management and general management consulting services. The opportunity was posted on July 2, 2026, with a response deadline of July 29, 2026, and is intended to support advanced research initiatives requiring expedited and compliant regulatory engagement. All work must be performed in alignment with federal guidelines, though no specific location for performance has been designated.
General Info
Agency
NAICS
Place of Performance
VASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
